Catherine Dollfus

Summary

Country: France

Publications

  1. doi request reprint Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10)
    C Dollfus
    Assistance Publique Hopitaux de Paris AP HP, Service d hématologie et d oncologie pédiatrique, Hopital d Enfants Armand Trousseau, Le Kremlin Bicetre, France
    Clin Infect Dis 51:214-24. 2010
  2. doi request reprint Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents
    C Dollfus
    Hopital Trousseau, Paris, France
    HIV Med 10:263-8. 2009
  3. ncbi request reprint [The role of chelating agents in childhood lead poisoning]
    Catherine Dollfus
    Service d hématologie et d oncologie pédiatrique, hôpital d enfants Armand Trousseau 75571 Paris Cedex 12
    Rev Prat 58:869-70. 2008
  4. doi request reprint Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?
    Carine Jasseron
    INSERM Unit 822, Le Kremlin Bicetre, Paris, France
    AIDS 22:1503-11. 2008
  5. doi request reprint No relation between in-utero exposure to HAART and intrauterine growth retardation
    Nelly Briand
    INSERM, U822, Le Kremlin Bicetre, France
    AIDS 23:1235-43. 2009
  6. doi request reprint Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Jeanne Sibiude
    CESP INSERM U1018, Le Kremlin Bicetre, Colombes, France
    Clin Infect Dis 54:1348-60. 2012
  7. ncbi request reprint Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort
    Josiane Warszawski
    INSERM, U822, IFR 60, Le Kremlin Bicetre, France
    AIDS 22:289-99. 2008
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
  9. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
  10. ncbi request reprint Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study
    Daniel Scott-Algara
    1 Unité Cytokines et Inflammation, Institut Pasteur, Paris, France
    AIDS Res Hum Retroviruses . 2016

Collaborators

Detail Information

Publications25

  1. doi request reprint Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10)
    C Dollfus
    Assistance Publique Hopitaux de Paris AP HP, Service d hématologie et d oncologie pédiatrique, Hopital d Enfants Armand Trousseau, Le Kremlin Bicetre, France
    Clin Infect Dis 51:214-24. 2010
    ..Given the limited therapeutic options available during the early years of these patients' lives and the challenge presented by treatment adherence during adolescence, the long-term outcomes among this population are encouraging...
  2. doi request reprint Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents
    C Dollfus
    Hopital Trousseau, Paris, France
    HIV Med 10:263-8. 2009
    ..We evaluated the patient satisfaction, safety and cosmetic results of HIV-infected adolescents who experienced autologous fat transplants for the correction of facial lipoatrophy...
  3. ncbi request reprint [The role of chelating agents in childhood lead poisoning]
    Catherine Dollfus
    Service d hématologie et d oncologie pédiatrique, hôpital d enfants Armand Trousseau 75571 Paris Cedex 12
    Rev Prat 58:869-70. 2008
  4. doi request reprint Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?
    Carine Jasseron
    INSERM Unit 822, Le Kremlin Bicetre, Paris, France
    AIDS 22:1503-11. 2008
    ..To investigate whether mother-to-child transmission (MTCT) management and rate differed between African immigrants and French-born women delivering in France...
  5. doi request reprint No relation between in-utero exposure to HAART and intrauterine growth retardation
    Nelly Briand
    INSERM, U822, Le Kremlin Bicetre, France
    AIDS 23:1235-43. 2009
    ..The use of HAART during pregnancy is now standard care to prevent mother-to-child HIV transmission in developed countries. There is controversy about its impact on low birth weight...
  6. doi request reprint Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Jeanne Sibiude
    CESP INSERM U1018, Le Kremlin Bicetre, Colombes, France
    Clin Infect Dis 54:1348-60. 2012
    ..We explored this question, focusing on the initiation of ritonavir-boosted protease inhibitors (PIs) during pregnancy, which is now standard care...
  7. ncbi request reprint Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort
    Josiane Warszawski
    INSERM, U822, IFR 60, Le Kremlin Bicetre, France
    AIDS 22:289-99. 2008
    ..To identify factors associated with mother-to-child HIV-1 transmission (MTCT) from mothers receiving antenatal antiretroviral therapy...
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
    ..Primary-HIV-1-infection in newborns that occurs under antiretroviral prophylaxis that is a high risk of drug-resistance acquisition. We examine the frequency and the mechanisms of resistance acquisition at the time of infection in newborns...
  9. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
    ..To evaluate the risk of late postnatal HIV-1 infection in nonbreastfed children enrolled in the French ANRS Cohort CO01 (EPF)...
  10. ncbi request reprint Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study
    Daniel Scott-Algara
    1 Unité Cytokines et Inflammation, Institut Pasteur, Paris, France
    AIDS Res Hum Retroviruses . 2016
    ..In conclusion, DC levels are a robust correlate of the presence of Gag-specific T cell proliferation in successfully treated youths...
  11. pmc Evaluation of nevirapine dosing recommendations in HIV-infected children
    Frantz Foissac
    EA 3620 Université Paris Descartes Sorbonne Paris Cité, Unité de RechercheClinique, Hôpital Tarnier, 89 rue d Assas, Paris, France
    Br J Clin Pharmacol 76:137-44. 2013
    ..The aims of this study were to investigate the population pharmacokinetics of NVP in children, establish factors that influence NVP pharmacokinetics and evaluate the current dosing recommendations...
  12. ncbi request reprint Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome
    Rasa Verkauskiene
    INSERM Unite, Hopital Robert Debre, Paris, France
    Pediatr Res 60:225-30. 2006
    ..In conclusion, HIV-infected children with symptoms of fat redistribution have decreased levels of adiponectin, associated with insulin resistance and dyslipidemia...
  13. ncbi request reprint Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1
    Albert Faye
    Pediatrie Generale, hôpital R Debré, Paris, France
    Clin Infect Dis 39:1692-8. 2004
    ..The clinical impact of early antiretroviral multidrug therapy on the risk of early-onset severe human immunodeficiency virus (HIV) disease has not been evaluated on a large scale...
  14. doi request reprint Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Nelly Briand
    Inserm U1018, Centre for research in Epidemiology and Population Health, Universite Paris Sud, Paris, France
    Clin Infect Dis 57:903-14. 2013
    ..We evaluated the impact of intravenous ZDV according to viral load and obstetrical conditions...
  15. doi request reprint Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children
    Camille Aupiais
    From the INSERM, Centre for research in Epidemiology and Population Health, U1018, Epidemiology of HIV and STI Team, Le Kremlin Bicetre, France AP HP, Robert Debre Hospital, Paris, France Univ Denis Diderot Paris 7, France AP HP, Necker Hospital, Paris, France Univ René Descartes, Paris 5, France AP HP, Trousseau Hospital, Paris, France Univ Paris Sud, Le Kremlin Bicetre, France and AP HP, Department of Public Health, Bicetre Hospital, Le Kremlin Bicetre, France
    Pediatr Infect Dis J 33:1237-45. 2014
    ..Antiretroviral treatment interruption (TI) is not recommended in HIV-infected children. We aimed to evaluate the context and consequences of TI in clinical practice...
  16. pmc Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)
    Jeanne Sibiude
    Hopital Louis Mourier, Assistance Publique Hopitaux de Paris, Colombes, France Centre de Recherche en Épidémiologie et Santé des Populations, Inserm U1018, Le Kremlin Bicetre, France
    PLoS Med 11:e1001635. 2014
    ..We estimated the prevalence of birth defects in children born to HIV-infected women receiving ART during pregnancy, and assessed the independent association of birth defects with each antiretroviral (ARV) drug used...
  17. pmc Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study
    Jerome Le Chenadec
    CESP INSERM U1018, Le Kremlin Bicetre, France
    PLoS ONE 10:e0144706. 2015
    ....
  18. ncbi request reprint Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children
    Marta Beregszaszi
    INSERM Unit 690, Hopital Robert Debre, Paris, France
    J Acquir Immune Defic Syndr 40:161-8. 2005
    ..To assess the rate of progression of lipodystrophy and the associated metabolic disturbances over a 2-year period in children and to assess risk factors associated with lipodystrophy and metabolic disturbances...
  19. doi request reprint Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study
    Coralie Briand
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Assistance Publique Hopitaux de Paris AP HP, Hôpital Universitaire Necker Enfants Malades, Paris, France
    J Antimicrob Chemother . 2016
    ..To assess the safety and efficacy of a dolutegravir-based regimen in perinatally HIV-1-infected adolescents...
  20. pmc Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents
    Frantz Foissac
    EA 3620 Université Paris Descartes, Paris, France
    Br J Clin Pharmacol 72:940-7. 2011
    ..To investigate atazanavir (ATV) population pharmacokinetics in children and adolescents, establish factors that influence ATV pharmacokinetics and investigate the ATV exposure after recommended doses...
  21. ncbi request reprint [A nursing consultation to improve antiretroviral medication management in children]
    Genevieve Vaudre
    Service d hématologie et d oncologie pédiatrique, Hopital d Enfants Armand Trousseau, AP HP, Paris
    Soins Pediatr Pueric . 2010
    ..It is above all through adopting a suitable technique as well as the motivation of the children that this objective can be achieved...
  22. doi request reprint HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report
    Pierre Frange
    Laboratoire de Microbiologie Clinique, Assistance Publique Hopitaux de Paris, Hopital Necker Enfants Malades, Paris, France Unité d Immunologie, Hématologie et Rhumatologie pédiatriques, Assistance Publique Hopitaux de Paris, Hopital Necker Enfants Malades, Paris, France EA7327, Universite Paris Descartes, Sorbonne Paris Cité, Paris, France Electronic address
    Lancet HIV 3:e49-54. 2016
    ..We report a case of a young adult perinatally infected with HIV-1 with viral remission despite long-term treatment interruption...
  23. ncbi request reprint Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort
    Béatrice Barret
    INSERM U569 Epidémiologie, Démographie et Sciences Sociales Hôpital Bicêtre AP HP, Le Kremlin Bicetre, France
    AIDS 17:1769-85. 2003
    ..Antiretroviral prevention of mother to child HIV-1 is established but tolerance remains to be assessed. AIM To determine the risk for persistent mitochondrial dysfunction in HIV-uninfected children born to seropositive mothers...
  24. doi request reprint Trichosporon: another yeast-like organism responsible for immune reconstitution inflammatory syndrome in patients with hematological malignancy
    Fanny Alby-Laurent
    Service d hémato oncologie pédiatrique, AP HP, Hopital A Trousseau, Paris, France
    Hematol Oncol . 2016
    ..Treatment with corticosteroid therapy led to clinical improvement in both cases. Copyright © 2016 John Wiley & Sons, Ltd...
  25. ncbi request reprint Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
    Albert Faye
    Service d Hémato immunologie, Hĵpital R Debré, Paris, France
    Pediatr Infect Dis J 21:518-25. 2002
    ..To assess tolerance and efficacy of early multitherapy including a protease inhibitor for infants perinatally infected with HIV...